Do the Results of RE-SPECT ESUS Call for a Revision of the Embolic Stroke of Undetermined Source Definition?

被引：18
作者：
Paciaroni, Maurizio [1 ,2 ]
Kamel, Hooman [3 ,4 ]
机构：
[1] Univ Perugia, Santa Maria della Misericordia Hosp, Stroke Unit, Perugia, Italy
[2] Univ Perugia, Santa Maria della Misericordia Hosp, Div Cardiovasc Med, Perugia, Italy
[3] Weill Cornell Med, Feil Family Brain & Mind Res Inst, Clin & Translat Neurosci Unit, New York, NY USA
[4] Weill Cornell Med, Dept Neurol, New York, NY USA
来源：
STROKE | 2019年 / 50卷 / 04期
关键词：
dabigatran; embolism; ESUS; rivaroxaban; secondary prevention; RANDOMIZED-TRIAL RATIONALE; DOUBLE-BLIND; PREVENTION; EFFICACY; ASPIRIN; SAFETY;
D O I：
10.1161/STROKEAHA.118.024160
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1032 / 1033
页数：2
相关论文
共 10 条
  • [1] Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial
    Amarenco, Pierre
    Albers, Gregory W.
    Denison, Hans
    Easton, J. Donald
    Evans, Scott R.
    Held, Peter
    Hill, Michael D.
    Jonasson, Jenny
    Kasner, Scott E.
    Ladenvall, Per
    Minematsu, Kazuo
    Molina, Carlos A.
    Wang, Yongjun
    Wong, K. S. Lawrence
    Johnston, S. Claiborne
    [J]. LANCET NEUROLOGY, 2017, 16 (04) : 301 - 310
  • [2] [Anonymous], [No title captured]
  • [3] Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
    Diener, Hans-Christoph
    Easton, J. Donald
    Granger, Christopher B.
    Cronin, Lisa
    Duffy, Christine
    Cotton, Daniel
    Brueckmann, Martina
    Sacco, Ralph L.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2015, 10 (08) : 1309 - 1312
  • [4] Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
    Eikelboom, J. W.
    Connolly, S. J.
    Bosch, J.
    Dagenais, G. R.
    Hart, R. G.
    Shestakovska, O.
    Diaz, R.
    Alings, M.
    Lonn, E. M.
    Anand, S. S.
    Widimsky, P.
    Hori, M.
    Avezum, A.
    Piegas, L. S.
    Branch, K. R. H.
    Probstfield, J.
    Bhatt, D. L.
    Zhu, J.
    Liang, Y.
    Maggioni, A. P.
    Lopez-Jaramillo, P.
    O'Donnell, M.
    Kakkar, A. K.
    Fox, K. A. A.
    Parkhomenko, A. N.
    Ertl, G.
    Stoerk, S.
    Keltai, M.
    Ryden, L.
    Pogosova, N.
    Dans, A. L.
    Lanas, F.
    Commerford, P. J.
    Torp-Pedersen, C.
    Guzik, T. J.
    Verhamme, P. B.
    Vinereanu, D.
    Kim, J. -H.
    Tonkin, A. M.
    Lewis, B. S.
    Felix, C.
    Yusoff, K.
    Steg, P. G.
    Metsarinne, K. P.
    Bruns, N. Cook
    Misselwitz, F.
    Chen, E.
    Leong, D.
    Yusuf, S.
    Aboyans, V.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14) : 1319 - 1330
  • [5] Prevalence of Nonstenosing, Complicated Atherosclerotic Plaques in Cryptogenic Stroke
    Freilinger, Tobias M.
    Schindler, Andreas
    Schmidt, Caroline
    Grimm, Jochen
    Cyran, Clemens
    Schwarz, Florian
    Bamberg, Fabian
    Linn, Jennifer
    Reiser, Maximilian
    Yuan, Chun
    Nikolaou, Konstantin
    Dichgans, Martin
    Saam, Tobias
    [J]. JACC-CARDIOVASCULAR IMAGING, 2012, 5 (04) : 397 - 405
  • [6] Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study design
    Geisler, Tobias
    Poli, Sven
    Meisner, Christoph
    Schreieck, Juergen
    Zuern, Christine S.
    Naegele, Thomas
    Brachmann, Johannes
    Jung, Werner
    Gahn, Georg
    Schmid, Elisabeth
    Baeezner, Hansjoerg
    Keller, Timea
    Petzold, Gabor C.
    Schrickel, Jan-Wilko
    Liman, Jan
    Wachter, Rolf
    Schoen, Frauke
    Schabet, Martin
    Lindner, Alfred
    Ludolph, Albert C.
    Kimmig, Hubert
    Jander, Sebastian
    Schlegel, Uwe
    Gawaz, Meinrad
    Ziemann, Ulf
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2017, 12 (09) : 985 - 990
  • [7] Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
    Hart, R. G.
    Sharma, M.
    Mundl, H.
    Kasner, S. E.
    Bangdiwala, S. I.
    Berkowitz, S. D.
    Swaminathan, B.
    Lavados, P.
    Wang, Y.
    Wang, Y.
    Davalos, A.
    Shamalov, N.
    Mikulik, R.
    Cunha, L.
    Lindgren, A.
    Arauz, A.
    Lang, W.
    Czlonkowska, A.
    Eckstein, J.
    Gagliardi, R. J.
    Amarenco, P.
    Ameriso, S. F.
    Tatlisumak, T.
    Veltkamp, R.
    Hankey, G. J.
    Toni, D.
    Bereczki, D.
    Uchiyama, S.
    Ntaios, G.
    Yoon, B. -W.
    Brouns, R.
    Endres, M.
    Muir, K. W.
    Bornstein, N.
    Ozturk, S.
    O'Donnell, M. J.
    Basson, M. M. De Vries
    Pare, G.
    Pater, C.
    Kirsch, B.
    Sheridan, P.
    Peters, G.
    Weitz, J. I.
    Peacock, W. F.
    Shoamanesh, A.
    Benavente, O. R.
    Joyner, C.
    Themeles, E.
    Connolly, S. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (23) : 2191 - 2201
  • [8] Embolic strokes of undetermined source: the case for a new clinical construct
    Hart, Robert G.
    Diener, Hans-Christoph
    Coutts, Shelagh B.
    Easton, J. Donald
    Granger, Christopher B.
    O'Donnell, Martini J.
    Sacco, Ralph L.
    Connolly, Stuart J.
    [J]. LANCET NEUROLOGY, 2014, 13 (04) : 429 - 438
  • [9] The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods
    Kamel, Hooman
    Longstreth, W. T., Jr.
    Tirschwell, David L.
    Kronmal, Richard A.
    Broderick, Joseph P.
    Palesch, Yuko Y.
    Meinzer, Caitlyn
    Dillon, Catherine
    Ewing, Irene
    Spilker, Judith A.
    Di Tullio, Marco R.
    Hod, Eldad A.
    Soliman, Elsayed Z.
    Chaturvedi, Seemant
    Moy, Claudia S.
    Janis, Scott
    Elkind, Mitchell S. V.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2019, 14 (02) : 207 - 214
  • [10] Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
    Schwartz, G. G.
    Steg, P. G.
    Szarek, M.
    Bhatt, D. L.
    Bittner, V. A.
    Diaz, R.
    Edelberg, J. M.
    Goodman, S. G.
    Hanotin, C.
    Harrington, R. A.
    Jukema, J. W.
    Lecorps, G.
    Mahaffey, K. W.
    Moryusef, A.
    Pordy, R.
    Quintero, K.
    Roe, M. T.
    Sasiela, W. J.
    Tamby, J. -F.
    Tricoci, P.
    White, H. D.
    Zeiher, A. M.
    Aylward, Philip E.
    Drexel, Heinz
    Sinnaeve, Peter
    Dilic, Mirza
    Lopes, Renato D.
    Gotcheva, Nina N.
    Goodman, Shaun G.
    Prieto, Juan-Carlos
    Yong, Huo
    Lopez-Jaramillo, Patricio
    Pecin, Ivan
    Reiner, Zeljko
    Ostadal, Petr
    Poulsen, Steen Hvitfeldt
    Viigimaa, Margus
    Nieminen, Markku S.
    Danchin, Nicolas
    Chumburidze, Vakhtang
    Marx, Nikolaus
    Liberopoulos, Evangelos
    Montenegro Valdovinos, Pablo Carlos
    Tse, Hung-Fat
    Kiss, Robert Gabor
    Xavier, Denis
    Zahger, Doron
    Valgimigli, Marco
    Kimura, Takeshi
    Kim, Hyo Soo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22) : 2097 - 2107
1